117
Views
11
CrossRef citations to date
0
Altmetric
Drug Profile

Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults

Pages 1031-1037 | Published online: 09 Jan 2014

References

  • Greenberg WM, Citrome L. Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials. CNS Drug Rev.13(2), 137–177 (2007).
  • Centorrino F, Fogarty KV, Sani G, Salvatore P, Cimbolli P, Baldessarini RJ. Antipsychotic drug use: McLean Hospital, 2002. Hum. Psychopharmacol.20(5), 355–358 (2005).
  • Sernyak MJ, Rosenheck RA. Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006. Psychiatr. Serv.59(5), 567–569 (2008).
  • Citrome L, Jaffe A, Levine J. How dosing of ziprasidone in a state hospital system differs from product labeling. J. Clin. Psychiatry70(7), 975–982 (2009).
  • Citrome L. Using oral ziprasidone effectively: the food effect and dose–response. Adv. Ther.26(8), 739–748 (2009).
  • Ketter TA, Wang PO. Longer-term management of bipolar disorders. In: Handbook of Diagnosis and Treatment of Bipolar Disorders. Ketter TA (Ed.). American Psychiatric Publishing, Inc., Washington, DC, USA 251–330 (2010).
  • Shayegan DK, Stahl SM. Atypical antipsychotics: matching receptor profile to individual patient’s clinical profile. CNS Spectr.9(10 Suppl. 11), 6–14 (2004).
  • Miceli JJ, Glue P, Alderman J, Wilner K. The effect of food on the absorption of oral ziprasidone. Psychopharmacol. Bull.40(3), 58–68 (2007).
  • Gandelman K, Alderman JA, Glue P et al. The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open label, cross-over trial. J. Clin. Psychiatry70(1), 58–62 (2009).
  • Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. J. Clin. Psychiatry71(2), 130–137 (2010).
  • Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J. Affect. Disord.109(3), 251–263 (2008).
  • Suppes T, Vieta E, Liu S, Brecher M, Paulsson B; Trial 127 Investigators. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127). Am. J. Psychiatry166(4), 476–488 (2009).
  • Malhi GS, Adams D, Cahill CM, Dodd S, Berk M. The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice. Drugs69(15), 2063–2101 (2009).
  • Patil ST, Zhang L, Martenyi F et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat. Med.13(9), 1102–1107 (2007).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.